Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 05, 2024

SELL
$1.31 - $6.6 $3,450 - $17,384
-2,634 Reduced 2.63%
97,660 $644,000
Q3 2023

Nov 07, 2023

SELL
$1.39 - $2.29 $21,962 - $36,182
-15,800 Reduced 13.61%
100,294 $139,000
Q2 2023

Aug 04, 2023

SELL
$2.19 - $5.17 $40,510 - $95,634
-18,498 Reduced 13.74%
116,094 $254,000
Q1 2023

May 08, 2023

BUY
$3.37 - $6.3 $453,575 - $847,929
134,592 New
134,592 $477,000

Others Institutions Holding NKTX

About Nkarta, Inc.


  • Ticker NKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,656,800
  • Market Cap $127M
  • Description
  • Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...
More about NKTX
Track This Portfolio

Track New York Life Investment Management LLC Portfolio

Follow New York Life Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York Life Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on New York Life Investment Management LLC with notifications on news.